Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells

In non-small cell lung carcinoma (NSCLC), stimulation of toll-like receptor 7 (TLR7), a receptor for single stranded RNA, is linked to tumor progression and resistance to anticancer chemotherapy. However, the mechanism of this effect has been elusive. Here, using a murine model of lung adenocarcinom...

Full description

Bibliographic Details
Main Authors: Marion Dajon, Kristina Iribarren, Florent Petitprez, Solenne Marmier, Audrey Lupo, Mélanie Gillard, Hanane Ouakrim, Navas Victor, Di Bartolo Vincenzo, Pierre Emmanuel Joubert, Oliver Kepp, Guido Kroemer, Marco Alifano, Diane Damotte, Isabelle Cremer
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1505174
_version_ 1818295137513504768
author Marion Dajon
Kristina Iribarren
Florent Petitprez
Solenne Marmier
Audrey Lupo
Mélanie Gillard
Hanane Ouakrim
Navas Victor
Di Bartolo Vincenzo
Pierre Emmanuel Joubert
Oliver Kepp
Guido Kroemer
Marco Alifano
Diane Damotte
Isabelle Cremer
author_facet Marion Dajon
Kristina Iribarren
Florent Petitprez
Solenne Marmier
Audrey Lupo
Mélanie Gillard
Hanane Ouakrim
Navas Victor
Di Bartolo Vincenzo
Pierre Emmanuel Joubert
Oliver Kepp
Guido Kroemer
Marco Alifano
Diane Damotte
Isabelle Cremer
author_sort Marion Dajon
collection DOAJ
description In non-small cell lung carcinoma (NSCLC), stimulation of toll-like receptor 7 (TLR7), a receptor for single stranded RNA, is linked to tumor progression and resistance to anticancer chemotherapy. However, the mechanism of this effect has been elusive. Here, using a murine model of lung adenocarcinoma, we demonstrate a key role for TLR7 expressed by malignant (rather than by stromal and immune) cells, in the recruitment of myeloid derived suppressor cells (MDSCs), induced after TLR7 stimulation, resulting in accelerated tumor growth and metastasis. In adenocarcinoma patients, high TLR7 expression on malignant cells was associated with poor clinical outcome, as well as with a gene expression signature linked to aggressiveness and metastastic dissemination with high abundance of mRNA encoding intercellular adhesion molecule 1 (ICAM-1), cytokeratins 7 and 19 (KRT-7 and 19), syndecan 4 (SDC4), and p53. In addition, lung tumors expressing high levels of TLR7 have a phenotype of epithelial mesenchymal transition with high expression of vimentin and low abundance of E-cadherin. These data reveal a crucial role for cancer cell-intrinsic TLR7 expression in lung adenocarcinoma progression.
first_indexed 2024-12-13T03:42:52Z
format Article
id doaj.art-3d8711a3d69047dc912aa59845b4beaa
institution Directory Open Access Journal
issn 2162-402X
language English
last_indexed 2024-12-13T03:42:52Z
publishDate 2019-01-01
publisher Taylor & Francis Group
record_format Article
series OncoImmunology
spelling doaj.art-3d8711a3d69047dc912aa59845b4beaa2022-12-22T00:00:53ZengTaylor & Francis GroupOncoImmunology2162-402X2019-01-018110.1080/2162402X.2018.15051741505174Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsMarion Dajon0Kristina Iribarren1Florent Petitprez2Solenne Marmier3Audrey Lupo4Mélanie Gillard5Hanane Ouakrim6Navas Victor7Di Bartolo Vincenzo8Pierre Emmanuel Joubert9Oliver Kepp10Guido Kroemer11Marco Alifano12Diane Damotte13Isabelle Cremer14Institut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersUnité de de Biologie Cellulaire des Lymphocytes INSERM U1221, Institut PasteurUnité de de Biologie Cellulaire des Lymphocytes INSERM U1221, Institut PasteurInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersDepartments of Pathology and Thoracic Surgery, Hospital Cochin AP-HPInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersInstitut National de la Santé et de la Recherche Medicale (INSERM), UMRS1138, Centre de Recherche des CordeliersIn non-small cell lung carcinoma (NSCLC), stimulation of toll-like receptor 7 (TLR7), a receptor for single stranded RNA, is linked to tumor progression and resistance to anticancer chemotherapy. However, the mechanism of this effect has been elusive. Here, using a murine model of lung adenocarcinoma, we demonstrate a key role for TLR7 expressed by malignant (rather than by stromal and immune) cells, in the recruitment of myeloid derived suppressor cells (MDSCs), induced after TLR7 stimulation, resulting in accelerated tumor growth and metastasis. In adenocarcinoma patients, high TLR7 expression on malignant cells was associated with poor clinical outcome, as well as with a gene expression signature linked to aggressiveness and metastastic dissemination with high abundance of mRNA encoding intercellular adhesion molecule 1 (ICAM-1), cytokeratins 7 and 19 (KRT-7 and 19), syndecan 4 (SDC4), and p53. In addition, lung tumors expressing high levels of TLR7 have a phenotype of epithelial mesenchymal transition with high expression of vimentin and low abundance of E-cadherin. These data reveal a crucial role for cancer cell-intrinsic TLR7 expression in lung adenocarcinoma progression.http://dx.doi.org/10.1080/2162402X.2018.1505174tlr7lung adenocarcinomametastasisemtmdsc
spellingShingle Marion Dajon
Kristina Iribarren
Florent Petitprez
Solenne Marmier
Audrey Lupo
Mélanie Gillard
Hanane Ouakrim
Navas Victor
Di Bartolo Vincenzo
Pierre Emmanuel Joubert
Oliver Kepp
Guido Kroemer
Marco Alifano
Diane Damotte
Isabelle Cremer
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
OncoImmunology
tlr7
lung adenocarcinoma
metastasis
emt
mdsc
title Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
title_full Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
title_fullStr Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
title_full_unstemmed Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
title_short Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
title_sort toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
topic tlr7
lung adenocarcinoma
metastasis
emt
mdsc
url http://dx.doi.org/10.1080/2162402X.2018.1505174
work_keys_str_mv AT mariondajon tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT kristinairibarren tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT florentpetitprez tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT solennemarmier tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT audreylupo tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT melaniegillard tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT hananeouakrim tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT navasvictor tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT dibartolovincenzo tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT pierreemmanueljoubert tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT oliverkepp tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT guidokroemer tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT marcoalifano tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT dianedamotte tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells
AT isabellecremer tolllikereceptor7expressedbymalignantcellspromotestumorprogressionandmetastasisthroughtherecruitmentofmyeloidderivedsuppressorcells